visceral leishmaniasis

Current Status of Visceral Leishmaniasis ( Kala Aza) in Gansu Province

甘肃省黑热病（内脏利什曼病）的现状

Differential Diagnosis of Visceral Leishmaniasis, Progressive Disseminated Histoplasmosis and Penicilliosis Marneffei

内脏利什曼病、播散型组织胞浆菌病及马内菲青霉菌病的诊断和鉴别

Had a major impact on the control of malaria, Chagas disease, visceral leishmaniasis and other tropical diseases.

对控制疟疾、南美锥虫病、内脏利什曼病和其它热带疾病产生了重大、积极的影响。

Scientists are a step closer to developing the first ever blood test for the deadly infectious disease known as kala-azar, or visceral leishmaniasis.

科学家说他们向开发出第一种黑热病（内脏利什曼病）血液检测技术的目标又迈进了一步。

Children with serious Visceral Leishmaniasis can be secondary to hemophagocytic syndrome, such cases should be given timely treatment of primary infection. Unless the condition is critical, We can stop using the immune inhibitors.

严重黑热病患儿可继发嗜血细胞综合征表现，此类患儿病情凶险，需及时治疗原发感染，除非病情危重，可停止使用免疫抑制剂针对嗜血细胞综合征免疫化疗。

Visceral leishmaniasis also known as kala-azar is caused by the Leishmania parasite and transmitted to humans through biting insects such as sand flies.

内脏利什曼病（又称为黑热病）的病原体是利什曼原虫，它是通过白蛉等昆虫叮咬传播给人类的。

Iranian scientists have shown that a rapid and non-invasive diagnostic test for visceral leishmaniasis, or kala-azar, can distinguish between active, subclinical and latent cases of the disease.

伊朗科学家证明了对内脏利什曼病（即黑热病）的一种快速非侵入性诊断检验可以区分出活跃、亚临床和潜伏的利什曼病病例。